Comprehensive profiling of 8p11-12 amplification in breast cancer

Molecular Cancer Research

Volumn 3, Issue 12, 2005, Pages 655-667

  Gelsi Boyer, Véronique ^a   Orsetti, Béatrice ^b   Cervera, Nathalie ^a   Finetti, Pascal ^a   Sircoulomb, Fabrice ^a   Rougé, Carole ^b   Lasorsa, Laurence ^b   Letessier, Anne ^a   Ginestier, Christophe ^a   Monville, Florence ^a   Esteyriès, Séverine ^a   Adélaïde, José ^a   Esterni, Benjamin ^a   Henry, Catherine ^d   Ethier, Stephen P ^e   Bibeau, Frédéric ^c   Mozziconacci, Marie Joëlle ^a   Charafe Jauffret, Emmanuelle ^a   Jacquemier, Jocelyne ^a   Bertucci, François ^a   Birnbaum, Daniel ^a,b   Theillet, Charles ^b   Chaffanet, Max ^a   more..

^a INSTITUT PAOLI CALMETTES   (France)

^b INSERM   (France)

^c CENTRE VAL D AURELLE   (France)

^d RENNES UNIVERSITY HOSPITAL   (France)

^e Karmanos Cancer Institute and Department OfOncology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; FIBROBLAST GROWTH FACTOR RECEPTOR 1; KI 67 ANTIGEN; PROGESTERONE RECEPTOR; PROTEIN P53; TRANSCRIPTOME;

AMPLICON; AP3M2 GENE; ARTICLE; ASH2L GENE; BAG4 GENE; BREAST CANCER; BREAST CELL; BRF2 GENE; CANCER SURVIVAL; CHROMOSOME 8P; CHROMOSOME BREAKAGE; CHROMOSOME LOSS; CHROMOSOME REARRANGEMENT; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DDH DOMAIN CONTAINING 2 GENE; EIF4EBP1 GENE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE; GENE AMPLIFICATION; GENE EXPRESSION PROFILING; GENE MAPPING; GENE OVEREXPRESSION; HTPAP GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; IKBKB GENE; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; LOC114926 GENE; LSM1 GENE; ONCOGENE; POLB GENE; PRIORITY JOURNAL; RAB11F1P1 GENE; SLC20A2 GENE; SPFH2 GENE; TISSUE MICROARRAY; VDAC3 GENE; WOLF HIRSCHHORN SYNDROME CANDIDATE 1 LIKE 1 GENE;

BREAST NEOPLASMS; CELL LINE, TUMOR; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 8; DNA DAMAGE; GENE AMPLIFICATION; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ONCOGENES; TELOMERE; TISSUE ARRAY ANALYSIS;

EID: 29944447205     PISSN: 15417786     EISSN: None     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-05-0128     Document Type: Article

References (57)

1. Emi M, Fujiwara Y, Nakajima T, et al. Frequent loss of heterozygosity for loci on chromosome 8p in hepatocellular carcinoma, colorectal cancer, and lung cancer. Cancer Res 1992;52:5368-72.
2. Knowles MA, Shaw ME, Proctor AJ. Deletion mapping of chromosome 8 in cancers of the urinary bladder using restriction fragment length polymorphisms and microsatellite polymorphisms. Oncogene 1993;8:1357-64.
3. Adeyinka A, Kytola S, Mertens F, Pandis N, Larsson C. Spectral karyotyping and chromosome banding studies of primary breast carcinomas and their lymph node metastases. Int J Mol Med 2000;5:235-40.
4. Davidson JM, Gorringe KL, Chin SF, et al. Molecular cytogenetic analysis of breast cancer cell lines. Br J Cancer 2000;83:1309-17.
5. Forozan F, Mahlamaki EH, Monni O, et al. Comparative genomic hybridization analysis of 38 breast cancer cell lines: a basis for interpreting complementary DNA microarray data. Cancer Res 2000;60:4519-25.
6. Rummukainen J, Kytola S, Karhu R, Farnebo F, Larsson C, Isola JJ. Aberrations of chromosome S in 16 breast cancer cell lines by comparative genomic hybridization, fluorescence in situ hybridization, and spectral karyotyping. Cancer Genet Cytogenet 2001;126:1-7.
7. Charafe-Jauffret E, Moulin JF, Ginestier C, et al. Loss of heterozygosity at microsatellite markers from region p11-21 of chromosome 8 in microdissected breast tumor but not in peritumoral cells. Int J Oncol 2002;21:989-96.
8. Struski S, Doco-Fenzy M, Cornillet-Lefebvre P. Compilation of published comparative genomic hybridization studies. Cancer Genet Cytogenet 2002;135: 63-90.
9. Teixeira MR, Pandis N, Heim S. Cytogenetic clues to breast carcinogenesis. Genes Chromosomes Cancer 2002;33:1-16.
10. Ferti AD, Stamouli MI, Panani AD, Ferti AD, Raptis SA, Young BD. Molecular cytogenetic analysis of breast cancer: a combined multicolour fluorescence in situ hybridisation and G-banding study of uncultured tumour cells. Cancer Genet Cytogenet 2004;149:28-37.
11. Adams J, Williams SV, Aveyard JS, Knowles MA. Loss of heterozygosity analysis and DNA copy number measurement on 8p in bladder cancer reveals two mechanisms of allelic loss. Cancer Res 2005;65:66-75.
12. Adélaïde J, Huang HE, Murati A, et al. A recurrent chromosome translocation breakpoint in breast and pancreatic cancer cell lines targets the neuregulin/NRG1 gene. Genes Chromosomes Cancer 2003;37:333-45.
13. Huang HE, Chin SF, Ginestier C, et al. A recurrent chromosome breakpoint in breast cancer at the NRG1/neuregulin 1/heregulin gene. Cancer Res 2004;64: 6840-4.
14. Theillet C, Adélaïde J, Louason G, et al. FGFR1 and PLAT genes and DNA amplification at 8p12 in breast and ovarian cancers. Genes Chromosomes Cancer 1993;7:219-26.
15. Courjal F, Theillet C. Comparative genomic hybridization analysis of breast tumours with predetermined profiles of DNA amplification. Cancer Res 1997;57: 4368-77.
16. Adélaïde J, Chaffanei M, Imbert A, et al. Chromosome region 8p11-p21: refined mapping and molecular alterations in breast cancer. Genes Chromosomes Cancer 1998;22:186-99.
17. Ugolini F, Adélaïde J, Charafe-Jauffret E, et al. Differential expression assay of chromosome arm 8p genes identifies Frizzled-related (FRP1/FRZB) and fibroblast growth factor receptor 1 (FGFR1) as candidate breast cancer genes. Oncogene 1999;18:1903-10.
18. Saint-Ruf C, Gerbauli-Seurcau M, Viegas-Pequignot E, Zafrani B, Malfoy B, Dutrillaux B. Recurrent homogeneously staining regions in 8p1 in breast cancer and lack of amplification of POLB, LHRH, and PLAT genes. Cancer Genet Cytogenet 1991;52:27-35.
19. Pandis N, Jin Y, Gorunova L, et al. Chromosome analysis of 97 primary breast carcinomas: identification of eight karyotypic subgroups. Genes Chromosomes Cancer 1995;12:173-85.
20. Bernardino J, Apiou F, Gerbault-Seureau M, Malfoy B, Dutrillaux B. Characterization of recurrent homogeneously staining regions in 72 breast carcinomas. Genes Chromosomes Cancer 1998;23:100-8.
21. Ray ME, Yang ZQ, Albertson D, et al. Genomic and expression analysis of the 8p11-12 amplicon in human breast cancer cell lines. Cancer Res 2004;64:40-7.
22. Reyal F, Stransky N, Bernard-Pierrot I, et al. Visualizing chromosomes as transcriptome correlation maps: evidence of chromosomal domains containing co-expressed genes - a study of 130 invasive ductal breast carcinomas. Cancer Res 2005;65:1376-83.
23. Garcia MJ, Pole JC, Chin SF, et al. A 1 Mb minimal amplicon at 8p11-12 in breast cancer identifies new candidate oncogenes. Oncogene 2005;24:5235-45.
24. Prentice EM, Shadeo A, Lestou VS, et al. NRG1 gene rearrangements in clinical breast cancer: identification of an adjacent novel amplicon associated with poor prognosis. Oncogene 2005;24:7281-9.
25. Letessier A, Mozziconacci MJ, Murati A, et al. Multicolour-banding fluorescence in situ hybridisation (mbanding-FISH) to identify recurrent chromosomal alterations in breast tumour cell lines. Br J Cancer 2005;92:382-8.
26. Lueito R, Healy J, Alexander J, et al. Representational oligonucleotide microarray analysis: a high-resolution method to detect genome copy number variation. Genome Res 2003;13:2291-305.
27. Hyman E, Kauraniemi P, Hautaniemi S, et al. Impact of DNA amplification on gene expression patterns in breast cancer. Cancer Res 2002;62:6240-5.
28. Pollack JR, Sorlie T, Perou CM, et al. Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors. Proc Natl Acacl Sci U S A 2002;99:12963-8.
29. Yamamoto Y, Irie K, Asada M, Mino A, Mandai K, Takai Y. Direct binding of the human homologue of the Drosophila disc large tumor suppressor gene to seven-pass transmembrane proteins, tumor endothelial marker 5 (TEM5), and a novel TEM5-like protein. Oncogene 2004;23:3889-97.
30. Schweinfest CW, Graber MW, Chapman JM, Papas TS, Baron PL, Watson DK. CaSm: an Sm-like protein that contributes to the transformed state in cancer cells. Cancer Res 1997;57:2961-5.
31. Rew DA. Small RNAs: a new class of genome regulators and their significance. Eur J Surg Oncol 2003;29:764-5.
32. Fraser MM, Watson PM, Fraig MM, et al. CaSm-mediated cellular Transformation is associated with altered gene expression and messenger RNA stability. Cancer Res 2005;65:6228-36.
33. Conte N, Charafe-Jauffret E, Delaval B, et al. Carcinogenesis and translational controls: TACC1 is down-regulated in human cancers and associates with mRNA regulators. Oncogene 2002;21:5619-30.
34. Ugolini F, Charafe-Jauffret E, Bardou VJ, et al. WNT pathway and mammary carcinogenesis: loss of expression of candidate rumor suppressor gene SFRP1 in most invasive carcinomas except of the medullary type. Oncogene 2001;20: 5810-7.
35. Armes JE, Hammet F, de Silva M, et al. Candidate tumor-suppressor genes on chromosome arm 8p in early-onset and high-grade breast cancers. Oncogene 2004;23:5697-702.
36. Borrow J, Stanton VP, Jr., Andresen JM, et al. The translocation t(8;16)(p11;p13) of acute myeloid leukaemia fuses a putative acetyltransferase to the CREB-binding protein. Nat Genet 1996;14:33-41.
37. Masayesva BG, Ha P, Garrett-Mayer E, et al. Gene expression alterations over large chromosomal regions in cancers include multiple genes unrelated to malignant progression. Proc Natl Acad Sci U S A 2004;101:8715-20.
38. Cheng KW, Lahad JP, Kuo WL, et al. The RAB25 small GTPase determines aggressiveness of ovarian and breast cancers. Nat Med 2004;10:1251-6.
39. Coquelle A, Pipiras E, Toledo F, Buttin G, Debatisse M. Expression of fragile sites triggers intrachromosomal mammalian gene amplification and sets boundaries to early amplicuns. Cell 1997;89:215-25.
40. Kent WJ, Sugnet CW, Furcy TS, et al. The human genome browser at UCSC. Genome Res 2002;12:996-1006.
41. Prasad MA, Trybus TM, Wojno KJ, Macoska JA. Homozygous and frequent deletion of proximal 8p sequences in human prostate cancers: identification of a potential tumor suppressor gene site. Genes Chromosomes Cancer 1998;23: 255-62.
42. Livesey FJ. Netrins and netrin receptors. Cell Mol Life Sci 1999;56:62-8.
43. Thiebault K, Mazelin L, Pays L, et al. The netrin-1 receptors UNC5H are putative tumor suppressors controlling cell death commitment. Proc Natl Acad Sci U S A 2003;100:4173-8.
44. Engelkamp D. Cloning of three mouse unc5 genes and their expression patterns at mid-gestation. Mech Dev 2002;118:191-7.
45. Hamaguchi M, Meth JL, von Klitzing C, et al. DBC2, a candidate for a tumor suppressor gene involved in breast cancer. Proc Natl Acad Sci U S A 2002;99: 13647-52.
46. Möbus VJ, Moll R, Gerharz CD, et al. Differential characteristics of two new tumorigenic cell lines of human breast carcinoma origin. Int J Cancer 1998;77: 415-23.
47. Forozan F, Veldman R, Ammerman CA, et al. Molecular cytogenetic analysis of 11 new breast cancer cell lines. Br J Cancer 1999;81:1328-34.
48. Jacquemier J, Ginestier C, Rougemont J, et al. Protein expression profiling identifies subclasses of breast cancer and predicts prognosis. Cancer Res 2005;65: 767-79.
49. Orsetti B, Nugoli M, Cervera N, et al. Genomic and expression profiling of chromosome 17 in breast cancer reveals complex patterns of alterations and novel candidate genes. Cancer Res 2004;64:6453-60.
50. Irizarry RA, Hobbs B, Collin F, et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 2003;4:249-64.
51. Eisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A 1998;95: 14863-8.
52. Golub TR, Slonim DK, Tamayo P, et al. Molecular classification of cancer: class discovery and class predict ion by gene expression monitoring. Science 1999;286:531-7.
53. Bertucci F, Finetti P, Rougemont J, et al. Gene expression profiling for molecular characterization of inflammatory breast cancer and prediction of response to chemotherapy. Cancer Res 2004;64:8558-65.
54. Ginestier C, Charafe-Jauffret E, Bertucci F, et al. Distinct and complementary information provided by use of tissue and DNA microarrays in the study of breast tumor markers. Am J Pathol 2002;161:1223-33.
55. Courtay-Cahen C, Morris JS, Edwards PAW. Chromosome translocations in breast cancer with breakpoints at 8p12. Genomics 2000;66:15-25.
56. Chin SF, Daigo Y, Huang HE, et al. A simple and reliable pretreatment protocol facilitates fluorescent in situ hybridisation on tissue microarrays of paraffin wax embedded tumour samples. Mol Pathol 2003;56:275-9.
57. van der Burg M, Poulsen TS, Hunger SP, et al. Split-signal FISH for detection of chromosome aberrations in acute lymphoblastic leukemia. Leukemia 2004;18:895-908.